Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Caitlin W. Elgarten"'
Autor:
Haley Newman, Yimei Li, Yuan‐Shung V. Huang, Caitlin W. Elgarten, Regina M. Myers, Jenny Ruiz, Daniel J. Zheng, Alison Barz Leahy, Catherine Aftandilian, Staci D. Arnold, Kira Bona, M. Monica Gramatges, Mallorie B. Heneghan, Kelly W. Maloney, Arunkumar J. Modi, Rajen J. Mody, Elaine Morgan, Jeffrey Rubnitz, Naomi Winick, Jennifer J. Wilkes, Alix E. Seif, Brian T. Fisher, Richard Aplenc, Kelly D. Getz
Publikováno v:
Cancer Medicine, Vol 13, Iss 7, Pp n/a-n/a (2024)
Abstract Objective Examine the influence of household income on health‐related quality of life (HRQOL) among children with newly diagnosed acute myeloid leukemia (AML). Design Secondary analysis of data prospectively collected from pediatric patien
Externí odkaz:
https://doaj.org/article/9a27bd579aa24883a6ccbfc603b94c45
Autor:
Joseph H. Oved, Nora M. Gibson, Kimberly Venella, Caitlin W. Elgarten, Lisa Wray, Julia T. Warren, Timothy S. Olson
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Severe congenital neutropenia (SCN) is caused by germline mutations, most commonly in ELANE, impacting neutrophil maturation and leading to high risk of life-threatening infections. Most patients with ELANE-mutant SCN can achieve safe neutrophil coun
Externí odkaz:
https://doaj.org/article/6513bb6fcbd54929b6b72109d32eeff5
Autor:
Caitlin W. Elgarten, John A. Kairalla, Joel C. Thompson, Tamara P. Miller, Cindy Wang, Susan Conway, Mignon L. Loh, Elizabeth A. Raetz, Sumit Gupta, Rachel E. Rau, Anne Angiolillo, Karen R. Rabin, Sarah Alexander
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 745-750 (2023)
Abstract Hematologic malignancy is a risk factor for severe coronavirus disease 2019 (COVID‐19) in adults; however, data specific to children with leukemia are limited. High‐quality infectious adverse event data from the ongoing Children's Oncolo
Externí odkaz:
https://doaj.org/article/57edae85d0ba4b3fbd3daa30c6697185
Autor:
Jason L. Freedman, Dori M. Beeler, Alison Bowers, Natalie Bradford, Yin Ting Cheung, Maya Davies, L. Lee Dupuis, Caitlin W. Elgarten, Torri M. Jones, Tracey Jubelirer, Tamara P. Miller, Priya Patel, Charles A. Phillips, Hannah R. Wardill, Andrea D. Orsey
Publikováno v:
Cancers, Vol 15, Iss 23, p 5549 (2023)
The optimization of outcomes for pediatric cancer patients relies on the successful advancement of supportive care to ease the treatment burden and mitigate the long-term impacts of cancer therapy. Advancing pediatric supportive care requires researc
Externí odkaz:
https://doaj.org/article/925865d61d344fb2a887de68aabdc278
Autor:
Haley Newman, Yimei Li, Yuan-Shung V. Huang, Caitlin W Elgarten, Regina M. Myers, Jenny Ruiz, Allison Barz Leahy, Catherine Aftandilian, Staci D. Arnold, Kira O Bona, Mallorie M. Heneghan, M Monica Gramatges, Kelly W Maloney, Arunkumar J. Modi, Rajen Mody, Naomi J Winick, Elaine Morgan, Jennifer J. Wilkes, Alix E. Seif, Brian T. Fisher, Richard Aplenc, Kelly D. Getz
Publikováno v:
Blood. 140:11001-11003
Autor:
Caitlin W. Elgarten, William R. Otto, Luke Shenton, Madison T. Stein, Joseph Horowitz, Catherine Aftandilian, Staci D. Arnold, Kira O. Bona, Emi Caywood, Anderson B. Collier, M. Monica Gramatges, Meret Henry, Craig Lotterman, Kelly Maloney, Arunkumar J. Modi, Amir Mian, Rajen Mody, Elaine Morgan, Elizabeth A. Raetz, Anupam Verma, Naomi Winick, Jennifer J. Wilkes, Jennifer C. Yu, Richard Aplenc, Brian T. Fisher, Kelly D. Getz
Publikováno v:
Infection Control & Hospital Epidemiology. 44:222-229
Background:Bloodstream infections (BSIs) are a frequent cause of morbidity in patients with acute myeloid leukemia (AML), due in part to the presence of central venous access devices (CVADs) required to deliver therapy.Objective:To determine the diff
Autor:
Katelyn Oranges, Tracey Jubelirer, Yahui Wei, Lindsay Flanagan, Anne F. Reilly, Caitlin W Elgarten, Jane Mauro, Julie Vardaro, Jason L. Freedman, L. Charles Bailey, Colleen Croy, Caroline Diorio
Publikováno v:
JCO Oncology Practice. 18:e412-e419
PURPOSE: Chemotherapy-induced nausea and vomiting (CINV) is a very common side effect of pediatric cancer therapy. High-quality, evidence-based, pediatric-specific guidelines for prophylaxis and treatment of CINV are available. At many centers, guide
Autor:
Thomas Lehrnbecher, Paula D. Robinson, Roland A. Ammann, Brian Fisher, Priya Patel, Robert Phillips, Melissa P. Beauchemin, Fabianne Carlesse, Elio Castagnola, Bonnie L. Davis, Caitlin W. Elgarten, Andreas H. Groll, Gabrielle M. Haeusler, Christa Koenig, Maria E. Santolaya, Wim J.E. Tissing, Joshua Wolf, Sarah Alexander, Helen Hu, L. Lee Dupuis, Lillian Sung
Publikováno v:
Lehrnbecher, Thomas; Robinson, Paula D; Ammann, Roland A; Fisher, Brian; Patel, Priya; Phillips, Robert; Beauchemin, Melissa P; Carlesse, Fabianne; Castagnola, Elio; Davis, Bonnie L; Elgarten, Caitlin W; Groll, Andreas H; Haeusler, Gabrielle M; Koenig, Christa; Santolaya, Maria E; Tissing, Wim J E; Wolf, Joshua; Alexander, Sarah; Hu, Helen; Dupuis, L Lee; ... (2023). Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update. Journal of clinical oncology, 41(9), pp. 1774-1785. American Society of Clinical Oncology 10.1200/JCO.22.02224
PURPOSE To update a clinical practice guideline (CPG) for the empiric management of fever and neutropenia (FN) in pediatric patients with cancer and hematopoietic cell transplantation recipients. METHODS The International Pediatric Fever and Neutrope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38bea1c100ef79ec138209b4c72d4810
Autor:
Allison Barz Leahy, Yimei Li, Julie-An Talano, Caitlin W. Elgarten, Alix E. Seif, Yongping Wang, Bryon Johnson, Dimitri S. Monos, Stephan Kadauke, Timothy S. Olson, Jason Freedman, Lisa Wray, Stephan A. Grupp, Nancy Bunin
Publikováno v:
Blood Advances. 6:1175-1185
Unrelated donor (URD) hematopoietic stem cell transplant (HSCT) is associated with an increased risk of severe graft-versus-host disease (GVHD). TCRαβ/CD19 depletion may reduce this risk, whereas maintaining graft-versus-leukemia. Outcome data with
Autor:
John C. Molina, Yimei Li, William R. Otto, Tamara P. Miller, Kelly D. Getz, Carly Mccoubrey, Mark Ramos, Edward Krause, Lusha Cao, M. Monica Gramatges, Karen Rabin, Michael Scheurer, Caitlin W. Elgarten, Regina M. Myers, Alix E. Seif, Brian T. Fisher, Nirali N. Shah, Richard Aplenc
Publikováno v:
Pediatric bloodcancerREFERENCES. 70(1)
An adequate absolute lymphocyte count (ALC) is an essential first step in autologous chimeric antigen receptor (CAR) T-cell manufacturing. For patients with acute myelogenous leukemia (AML), the intensity of chemotherapy received may affect adequate